We all know there’s no such thing as a free lunch, but what’s not always clear is the cost. The U.S. federal government in two of its incarnations recently put those in the life science industries on alert that the cost of doing business might go up to a degree that may surprise anyone who hasn’t been paying attention. FDA proposed recently to make freely available “de-identified and masked data derived from medical product applications,” citing as a “national priority” the need to improve “the efficiency and effectiveness of...